NASDAQ:AMED
Amedisys Inc Stock News
$92.16
-0.300 (-0.324%)
At Close: Mar 28, 2024
Why Amedisys (AMED) is a Top Value Stock for the Long-Term
10:46am, Monday, 25'th Mar 2024
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Why Is Amedisys (AMED) Down 2.5% Since Last Earnings Report?
12:36pm, Friday, 22'nd Mar 2024
Amedisys (AMED) reported earnings 30 days ago. What's next for the stock?
How Amedisys (AMED) Stock Stands Out in a Strong Industry
10:01am, Wednesday, 20'th Mar 2024
Amedisys (AMED) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
Oregon's health authority reviewing UnitedHealth's acquisition of Amedisys
06:16pm, Tuesday, 19'th Mar 2024
Amedisys said on Tuesday Oregon's health authority has started a review of UnitedHealth Group's $3.3 billion acquisition of the home health and hospice caregiver.
AMED vs. USPH: Which Stock Is the Better Value Option?
12:41pm, Thursday, 22'nd Feb 2024
Investors interested in Medical - Outpatient and Home Healthcare stocks are likely familiar with Amedisys (AMED) and U.S. Physical Therapy (USPH). But which of these two stocks offers value investors
Amedisys (AMED) Reports Q4 Earnings: What Key Metrics Have to Say
09:01pm, Wednesday, 21'st Feb 2024
While the top- and bottom-line numbers for Amedisys (AMED) give a sense of how the business performed in the quarter ended December 2023, it could be worth looking at how some of its key metrics compa
Amedisys (AMED) Q4 Earnings Lag Estimates
07:01pm, Wednesday, 21'st Feb 2024
Amedisys (AMED) came out with quarterly earnings of $0.94 per share, missing the Zacks Consensus Estimate of $1.04 per share. This compares to earnings of $1.16 per share a year ago.
Amedisys (AMED) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release
11:06am, Wednesday, 14'th Feb 2024
Amedisys (AMED) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Amedisys (AMED) Up 2.6% Since Last Earnings Report: Can It Continue?
12:47pm, Thursday, 23'rd Nov 2023
Amedisys (AMED) reported earnings 30 days ago. What's next for the stock?
Amedisys, Inc.: Why Stock Is A Hold Pending Agency Review
10:08am, Friday, 03'rd Nov 2023
Amedisys, Inc. is set to be acquired by UnitedHealth Group in a $3.29 billion merger agreement. Some US legislators have called for further scrutiny of the merger, citing concerns of increased market
Amedisys (AMED) Reports Q3 Earnings: What Key Metrics Have to Say
09:02pm, Tuesday, 24'th Oct 2023
Although the revenue and EPS for Amedisys (AMED) give a sense of how its business performed in the quarter ended September 2023, it might be worth considering how some key metrics compare with Wall St
Amedisys (AMED) Q3 Earnings and Revenues Lag Estimates
07:33pm, Tuesday, 24'th Oct 2023
Amedisys (AMED) came out with quarterly earnings of $0.98 per share, missing the Zacks Consensus Estimate of $1.08 per share. This compares to earnings of $1.15 per share a year ago.
Is Amedisys (AMED) Stock Outpacing Its Medical Peers This Year?
11:19am, Wednesday, 18'th Oct 2023
Here is how Amedisys (AMED) and Cybin Inc. (CYBN) have performed compared to their sector so far this year.
Amedisys (AMED) Q2 Earnings Beat Estimates, Margins Dip
01:15pm, Friday, 28'th Jul 2023
Strength in Hugh Acuity Care segment and Hospice division drive Amedisys (AMED) Q2 performance.
Amedisys (AMED) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
11:41pm, Wednesday, 26'th Jul 2023
While the top- and bottom-line numbers for Amedisys (AMED) give a sense of how the business performed in the quarter ended June 2023, it could be worth looking at how some of its key metrics compare t